994 related articles for article (PubMed ID: 18230571)
1. [Immune response and cancer].
El Hage F; Abouzahr-Rifai S; Meslin F; Mami-Chouaib F; Chouaib S
Bull Cancer; 2008 Jan; 95(1):57-67. PubMed ID: 18230571
[TBL] [Abstract][Full Text] [Related]
2. Tumor-host immune interactions and dendritic cell dysfunction.
Yang L; Carbone DP
Adv Cancer Res; 2004; 92():13-27. PubMed ID: 15530555
[TBL] [Abstract][Full Text] [Related]
3. From cancer immunosurveillance to cancer immunotherapy.
Stagg J; Johnstone RW; Smyth MJ
Immunol Rev; 2007 Dec; 220():82-101. PubMed ID: 17979841
[TBL] [Abstract][Full Text] [Related]
4. [Antitumor immunity and cellular cancer therapies].
Catros-Quemener V; Bouet F; Genetet N
Med Sci (Paris); 2003 Jan; 19(1):43-53. PubMed ID: 12836191
[TBL] [Abstract][Full Text] [Related]
5. Tumour escape mechanisms and their therapeutic implications in combination tumour therapy.
Bhutia SK; Mallick SK; Maiti TK
Cell Biol Int; 2010 Apr; 34(5):553-63. PubMed ID: 20384587
[TBL] [Abstract][Full Text] [Related]
6. Improving cancer immunotherapy by targeting tumor-induced immune suppression.
Stewart TJ; Smyth MJ
Cancer Metastasis Rev; 2011 Mar; 30(1):125-40. PubMed ID: 21249424
[TBL] [Abstract][Full Text] [Related]
7. [Immune tolerance and active suppression in oncology. Immunological principles and therapeutic options].
Stremmel C; Klein P; Hohenberger W
Chirurg; 2002 Mar; 73(3):255-61. PubMed ID: 11963500
[TBL] [Abstract][Full Text] [Related]
8. Therapeutics targeting tumor immune escape: towards the development of new generation anticancer vaccines.
Mocellin S; Nitti D
Med Res Rev; 2008 May; 28(3):413-44. PubMed ID: 17694549
[TBL] [Abstract][Full Text] [Related]
9. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
Khawli LA; Hu P; Epstein AL
Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
[TBL] [Abstract][Full Text] [Related]
10. [Cancer immunotherapy. Importance of overcoming immune suppression].
Malvicini M; Puchulo G; Matar P; Mazzolini G
Medicina (B Aires); 2010; 70(6):565-70. PubMed ID: 21163748
[TBL] [Abstract][Full Text] [Related]
11. Targeted therapies to improve tumor immunotherapy.
Begley J; Ribas A
Clin Cancer Res; 2008 Jul; 14(14):4385-91. PubMed ID: 18628452
[TBL] [Abstract][Full Text] [Related]
12. Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance.
Mapara MY; Sykes M
J Clin Oncol; 2004 Mar; 22(6):1136-51. PubMed ID: 15020616
[TBL] [Abstract][Full Text] [Related]
13. Suppressive influences in the immune response to cancer.
Bronte V; Mocellin S
J Immunother; 2009 Jan; 32(1):1-11. PubMed ID: 19307988
[TBL] [Abstract][Full Text] [Related]
14. [Immunotherapy of cancer: promise and reality].
Chouaib S; El Hage F; Benlalam H; Mami-Chouaib F
Med Sci (Paris); 2006; 22(8-9):755-9. PubMed ID: 16962052
[TBL] [Abstract][Full Text] [Related]
15. Tumor escape from immune surveillance.
Costello RT; Gastaut JA; Olive D
Arch Immunol Ther Exp (Warsz); 1999; 47(2):83-8. PubMed ID: 10202560
[TBL] [Abstract][Full Text] [Related]
16. Commentary: Immune escape versus tumor tolerance: how do tumors evade immune surveillance?
Salih HR; Nüssler V
Eur J Med Res; 2001 Aug; 6(8):323-32. PubMed ID: 11549514
[TBL] [Abstract][Full Text] [Related]
17. Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.
Peggs KS; Quezada SA; Allison JP
Immunol Rev; 2008 Aug; 224():141-65. PubMed ID: 18759925
[TBL] [Abstract][Full Text] [Related]
18. Immunosurveillance and immunoediting--can the immune response be made more "immunodemocratic"?
Mincheff M
J BUON; 2009 Sep; 14 Suppl 1():S89-96. PubMed ID: 19785075
[TBL] [Abstract][Full Text] [Related]
19. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting.
Gray A; Raff AB; Chiriva-Internati M; Chen SY; Kast WM
Immunol Rev; 2008 Apr; 222():316-27. PubMed ID: 18364011
[TBL] [Abstract][Full Text] [Related]
20. The promise of 4-1BB (CD137)-mediated immunomodulation and the immunotherapy of cancer.
Lynch DH
Immunol Rev; 2008 Apr; 222():277-86. PubMed ID: 18364008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]